Home  >  Products  >  TBC1D2B (TBC1 domain family, member 2B ) Blocking Peptide (the C terminal of TBC1D2B)(100ug)
TBC1D2B (TBC1 domain family, member 2B ) Blocking Peptide (the C terminal of TBC1D2B)(100ug)

TBC1D2B (TBC1 domain family, member 2B ) Blocking Peptide (the C terminal of TBC1D2B)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TBC1D2B Antibody (ARP31801_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP31801
Size: 100ug
Weight: 91kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: TBC1D2B may act as a GTPase-activating protein.
Alternative names: FLJ20166; KIAA1055